JSR Life Sciences is committed to the advancement of human health worldwide as a strategic partner to companies that discover, develop & deliver products to treat disease & improve quality of life
Crown Bioscience is a contract research & translational technology company making precision medicine a reality
KBI Biopharma is an award winning CDMO providing fully-integrated, accelerated drug development & biomanufacturing services to pharmaceutical & biotechnology companies globally
MBL is committed to being a leading manufacturer & supplier of diagnostic reagents that facilitate further advances in personalized medicine & individualization of medical care
JSR Corporation's mission is to contribute to social good by supplying materials to serve future generations & providing new value today for their customers & society
Browse through all our news
View notable news mentions
Find contact details
~ Services and Capacity Increase with New Site Opening ~
Paper describes well-established protocols for PDAC orthotopic tumor homograft model development and immunoprofiling
The Company Offers New Non-GLP Services & Translational Rodent Models at its expanded site in Louisiana
Updates enhance user experience, provide comprehensive characterization data, and add new models
Unique well-characterized prostate models derived from castration resistant and hormone sensitive primary tissue now available for studies
CrownBio will market a set of new, highly characterized breast cancer models alongside their industry leading collection of more than 2500 PDX models (HuPrime®).
Claudin18.2 specific CAR-T cells show tumor elimination in PDX models
Alliance enables researchers to access thousands of GEMMs
Humanized Model Expansion Program begins with PD-1, CTLA-4, and CD137 Models
"Cancer Research Center of Lyon iPS novel PDX models formulate new immune cell focused strategies"
Your information is only used to send you news and will never be shared with third parties. Your personal data will be processed in accordance with JSR Life Sciences's Privacy Policy.
Thank you for subscribing–we're almost there. We just need to confirm your email address so we know we're sending news to the right person.
The confirmation email will arrive in your inbox shortly.
You can close this window.
Find news releases, media kits and clippings